Press coverage about CME Group (NASDAQ:CME) has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CME Group earned a media sentiment score of 0.09 on Accern’s scale. Accern also gave news headlines about the financial services provider an impact score of 46.1113489921873 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

These are some of the news articles that may have impacted Accern’s scoring:

Several analysts have recently weighed in on CME shares. BidaskClub upgraded CME Group from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, September 27th. Barclays lifted their target price on CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 10th. UBS reiterated a “buy” rating and set a $135.00 target price (up from $134.00) on shares of CME Group in a research report on Wednesday, September 6th. Royal Bank Of Canada lifted their target price on CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a research report on Monday, October 16th. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and set a $127.00 target price on shares of CME Group in a research report on Friday, August 18th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $141.75.

CME Group (NASDAQ:CME) traded up $0.75 during mid-day trading on Monday, hitting $152.82. The company had a trading volume of 1,493,900 shares, compared to its average volume of 1,373,500. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.05 and a quick ratio of 1.05. The company has a market capitalization of $51,823.55, a P/E ratio of 31.97, a P/E/G ratio of 3.14 and a beta of 0.73. CME Group has a 12-month low of $113.27 and a 12-month high of $155.29.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 earnings per share for the quarter, beating the consensus estimate of $1.16 by $0.03. The firm had revenue of $890.80 million during the quarter, compared to the consensus estimate of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the company posted $1.05 earnings per share. analysts predict that CME Group will post 4.78 EPS for the current year.

The company also recently announced a None dividend, which will be paid on Monday, January 15th. Shareholders of record on Thursday, December 28th will be issued a $3.50 dividend. The ex-dividend date is Wednesday, December 27th. CME Group’s dividend payout ratio is presently 59.86%.

In other CME Group news, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction dated Wednesday, October 11th. The shares were sold at an average price of $136.83, for a total value of $342,075.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Julie Winkler sold 2,457 shares of the business’s stock in a transaction dated Thursday, December 7th. The stock was sold at an average price of $150.41, for a total transaction of $369,557.37. Following the completion of the transaction, the insider now owns 16,318 shares of the company’s stock, valued at $2,454,390.38. The disclosure for this sale can be found here. Insiders sold 36,628 shares of company stock valued at $5,288,800 over the last quarter. 0.57% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: This news story was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/12/11/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-cme-group-cme-stock-price.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Stock Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related stocks with our FREE daily email newsletter.